Assessing deviations for HPCs obtained during COVID-19 (ADHOC): Evaluating impact of the COVID-19 pandemic on cellular therapy products and processes, the BEST collaborative study.

Suzanne R Thibodeaux, Dean Coble, Victoria Day,Magali J Fontaine,Maria Gabelli,Nicola Gardiner, Tamara Geach,Joseph Schwartz,Ljiljana V Vasovic, Rachael Wyre,John Girdlestone

Transfusion（2023）

引用 0|浏览20

暂无评分

摘要

While there were no apparent changes to most parameters studied, there was an indication of slower neutrophil engraftment that will need to be examined in larger, longer term studies.

查看译文

关键词

COVID-19,cellular therapy product quality,cryopreservation,hematopoietic stem cell

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要